Association of serum phosphorus level with anemia in kidney transplant recipients

Transplantation

Volumn 91, Issue 8, 2011, Pages 875-882

  Kovesdy, Csaba P ^a,b   Mucsi, Istvan ^c,d   Czira, Maria E ^c   Rudas, Anna ^c   Ujszaszi, Akos ^c   Rosivall, Laszlo ^c   Kim, S Joseph ^e   Wolf, Myles ^f   Molnar, Miklos Z ^c,g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Anemia; Hemoglobin; Kidney transplant; Serum phosphorus

Indexed keywords

25 HYDROXYVITAMIN D; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ANEMIA; ARTICLE; BONE DISEASE; BONE MINERAL; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; IRON DEFICIENCY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANEMIA; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; HUNGARY; KIDNEY TRANSPLANTATION; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; PHOSPHORUS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 79954708035     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182111edf     Document Type: Article

References (34)

1. Oniscu GC, Brown H, Forsythe JL. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005; 16: 1859.
2. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: A European survey. Am J Transplant 2003; 3: 835.
3. Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients-A prospective cohort study. Am J Transplant 2007; 7: 818.
4. Djamali A, Samaniego M, Muth B, et al. Medical care of kidney transplant recipients after the first posttransplant year. Clin JAmSoc Nephrol 2006; 1: 623.
5. Sprague SM, Belozeroff V, Danese MD, et al. Abnormal bone and mineral metabolism in kidney transplant patients-A review.AmJ Nephrol 2008; 28: 246.
6. Monier-Faugere MC, Mawad H, Qi Q, et al. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000; 11: 1093.
7. Schaeffner ES, Fodinger M, Kramar R, et al. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int 2007; 20: 247.
8. Suwelack B, Gerhardt U, Witta J, et al. Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation. Am J Hypertens 2001; 14: 1012.
9. Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease. Am J Nephrol 2009; 30: 64.
10. Kiss Z, Ambrus C, Almasi C, et al. Serum 25OH-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 2010; 17: c373.
11. Patel NM, Gutierrez OM, Andress DL, et al. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010; 77: 715.
12. Kimata N, Akiba T, Pisoni RL, et al. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2005; 20: 927.
13. Meytes D, Bogin E, Ma A, et al. Effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981; 67: 1263.
14. Kalantar-Zadeh K, Lee GH, Miller JE, et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 2009; 53: 823.
15. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993; 328: 171.
16. Lin CL, Hung CC, Yang CT, et al. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail 2004; 26: 289.
17. Tonelli M, Blake PG, Muirhead N. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. ASAIO J 2001; 47: 82.
18. Diskin CJ, Stokes TJ, Dansby LM, et al. Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients? Nephrology (Carlton) 2006; 11: 394.
19. Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in predialysis CKD. Int Urol Nephrol 2008; 40: 427.
20. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J AmSoc Nephrol 2005; 16: 520.
21. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 2010; 73: 268.
22. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879.
23. Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627.
24. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10.
25. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 2006; 69: 560.
26. Regidor DL, Kopple JD, Kovesdy CP, et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J AmSoc Nephrol 2006; 17: 1181.
27. Kempe DS, Ackermann TF, Fischer SS, et al. Accelerated suicidal erythrocyte death in Klotho-deficient mice. Pflugers Arch 2009; 458: 503.
28. Imanishi Y, Koyama H, Inaba M, et al. Phosphorus intake regulates intestinal function and polyamine metabolism in uremia. Kidney Int 1996; 49: 499.
29. Yoshida K, Yoneda T, Kimura S, et al. Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay. Ther Apher Dial 2006; 10: 267.
30. Molnar MZ, Keszei A, Czira ME, et al. Evaluation of the malnutritioninflammation score in kidney transplant recipients. Am J Kidney Dis 2010; 56: 102.
31. Ambrus C, Molnar MZ, Czira ME, et al. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients. Int Urol Nephrol 2009; 41: 1029.
32. Kovesdy CP, Molnar MZ, Czira ME, et al. Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin J Am Soc Nephrol 2010; 5: 2297.
33. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
34. Thadhani R, Tonelli M. Cohort studies: Marching forward. Clin J Am Soc Nephrol 2006; 1: 1117.